Press MF - Search Results

1

Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.

Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF. Saffari B, et al. Among authors: press mf. Cancer Res. 1995 Dec 1;55(23):5693-8. Cancer Res. 1995. PMID: 7585656

2

Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

Press MF, Cordon-Cardo C, Slamon DJ. Press MF, et al. Oncogene. 1990 Jul;5(7):953-62. Oncogene. 1990. PMID: 1973830

3

HER-2/neu oncogene amplification and expression in breast and ovarian cancers.

Press MF, Jones LA, Godolphin W, Edwards CL, Slamon DJ. Press MF, et al. Prog Clin Biol Res. 1990;354A:209-21. Prog Clin Biol Res. 1990. PMID: 1978943 Review. No abstract available.

4

Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis.

Press MF, Pike MC, Hung G, Zhou JY, Ma Y, George J, Dietz-Band J, James W, Slamon DJ, Batsakis JG, et al. Press MF, et al. Cancer Res. 1994 Nov 1;54(21):5675-82. Cancer Res. 1994. PMID: 7522962

5

[Prognostic differentiation of ovarian carcinomas by immunohistochemical analysis of estrogen receptor expression].

Kieback DG, Press MF, McCamant SK, Atkinson EN, Möbus VJ, Runnebaum IB, Kreienberg R, Jones LA. Kieback DG, et al. Among authors: press mf. Geburtshilfe Frauenheilkd. 1995 Apr;55(4):189-94. doi: 10.1055/s-2007-1023299. Geburtshilfe Frauenheilkd. 1995. PMID: 7789706 German.

6

Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.

Press MF, Hung G, Godolphin W, Slamon DJ. Press MF, et al. Cancer Res. 1994 May 15;54(10):2771-7. Cancer Res. 1994. PMID: 7909495

7

Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.

Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R, et al. Press MF, et al. Cancer Res. 1993 Oct 15;53(20):4960-70. Cancer Res. 1993. PMID: 8104689

8

Prognostic significance of estrogen receptor expression in ovarian cancer. Immunoreactive Score (IRS) vs. Composition Adjusted Receptor Level (CARL).

Kieback DG, Press MF, Atkinson EN, Edwards GL, Möbus VJ, Runnebaum IB, Kreienberg R, Jones LA. Kieback DG, et al. Among authors: press mf. Anticancer Res. 1993 Nov-Dec;13(6B):2489-96. Anticancer Res. 1993. PMID: 8135488

9

Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor.

Kieback DG, McCamant SK, Press MF, Atkinson EN, Gallager HS, Edwards CL, Hajek RA, Jones LA. Kieback DG, et al. Among authors: press mf. Cancer Res. 1993 Nov 1;53(21):5188-92. Cancer Res. 1993. PMID: 8221656

10

Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma.

Felix A, El-Naggar AK, Press MF, Ordonez NG, Fonseca I, Tucker SL, Luna MA, Batsakis JG. Felix A, et al. Among authors: press mf. Hum Pathol. 1996 Jun;27(6):561-6. doi: 10.1016/s0046-8177(96)90162-8. Hum Pathol. 1996. PMID: 8666365

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters